Another possible target to eliminate HNSCC CSCs and cisplatin resistance is the SDCBP (Syndecan-binding protein), a central contributor in different phases of the metastasis cascade[137,138]. The gene discussed is SDCBP; the disease is head and neck squamous cell carcinoma.